Flexible single-use manufacturing technologies at an advanced global site
Our facility employs state-of-the-art single use mammalian cell culture technologies in upstream and downstream process development mirrored in design with our cGMP manufacturing for consistent and robust tech transfer and scale-up. From cell line development through cGMP production along with associated analytical development and validation, Bora delivers high-yield, high-quality processes for our client programs – even with the most challenging molecules.
Take a look at our biologics site in Zhubei, Taiwan.
From Lab to Manufacture – Bora ensures Comprehensive Transfer Solutions
Bora Biologics ensures smooth technology transfer throughout the product development lifecycle, offering expertise in scaling biologics processes from laboratory to cGMP manufacturing scales. We employ advanced scale-down, scale-up and scale-out technologies to facilitate seamless transitions and provide systematic process gap analyses for clients undergoing site or equipment changes in collaboration with Bora.
Offering end-to-end solutions for biologics
Our US-based sterile fill/finish manufacturing site in Baltimore, MD specializes in aseptic filling of vials (liquid/lyophilized) & pre-filled syringes for high-value biological drug products. We provide efficient tech transfer and scale up from early to late-stage production and offer flexible and scalable solutions designed to fit your unique cGMP program needs.
Leveraging state-of-the-art isolator technology and highly skilled manufacturing experts equipped to handle high-value biologics, Bora is ideally positioned and well-suited to support your complex clinical and commercial projects.
Learn more about our Baltimore sterile fill/finish facility.
